Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT

BACKGROUND: The randomized, placebo-controlled COLCOT (Colchicine Cardiovascular Outcomes Trial) has shown the benefits of colchicine 0.5 mg daily to lower the rate of ischemic cardiovascular events in patients with a recent myocardial infarction. Here, we conducted a post hoc pharmacogenomic study...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Circ Genom Precis Med
Glavni autori: Dubé, Marie-Pierre, Legault, Marc-André, Lemaçon, Audrey, Lemieux Perreault, Louis-Philippe, Fouodjio, René, Waters, David D., Kouz, Simon, Pinto, Fausto J., Maggioni, Aldo P., Diaz, Rafael, Berry, Colin, Koenig, Wolfgang, Lopez-Sendon, Jose, Gamra, Habib, Kiwan, Ghassan S., Asselin, Géraldine, Provost, Sylvie, Barhdadi, Amina, Sun, Maxine, Cossette, Mariève, Blondeau, Lucie, Mongrain, Ian, Dubois, Anick, Rhainds, David, Bouabdallaoui, Nadia, Samuel, Michelle, de Denus, Simon, L’Allier, Philippe L., Guertin, Marie-Claude, Roubille, François, Tardif, Jean-Claude
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2021
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284376/
https://ncbi.nlm.nih.gov/pubmed/33560138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCGEN.120.003183
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items